To view this email as a web page, click here.

Conference Coverage
 
How Immuno-Oncology Biomarkers Are Changing Cancer Care
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.
Read More
 
Understanding Both Sides of the Copay Accumulator Debate
At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.
Read More
ADVERTISEMENT
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.